At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com or by phone at 1-800-839-2486 for domestic calls and area ...

Alterations in the expression and activity of specific translation factors, and the uncoupling of translational regulation from inhibition by tumour cell stresses, such as hypoxia and nutrient ...

Translational research involves the application of knowledge gained through basic research to studies that could support the development of new products. For example, translational research in the ...

Ivo Jurek; Chief Executive Officer, Executive Director; Gates Industrial Corporation PLC L. Brooks Mallard; Chief Financial Officer, Executive Vice President; Gates Industrial Corporation PLC Good ...

Gates Industrial Corporation plc ( NYSE: GTES) Q4 2024 Earnings Conference Call February 6, 2025 11:00 AM ET Rich Kwas – Investor Relations Ivo Jurek – Chief Executive Officer Brooks Mallard – ...

Company Delivers Revenue, Margin and Earnings Ahead of its Expectations Revenue of $5.2 billion increased 9.8% as reported, 9.6% currency-neutral and 3.9% ...

The FDA has approved an expanded label for Roche’s PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody test, which ...

This valuable study presents a mouse gastruloid model that can be used to generate hematopoietic progenitors as well as leukemic cells. However, in its current form, the manuscript is inadequate ...

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, has entered into a ...

Q1 2025 Management View Tom Polen emphasized several key updates, including the planned separation of BD’s Biosciences and Diagnostic Solutions businesses, which aims to create two strategically ...

This study presents a useful finding that targeting amino acid metabolism can overcome Trastuzumab resistance in HER2+ breast cancer. The evidence supporting the claims of the authors is solid and the ...